| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.10B | +3.5% |
| Cost of Revenue | $1.69B | -3.5% |
| Gross Profit | $2.41B | +9.1% |
| R&D Expense | $25.6M | +19.6% |
| SG&A Expense | $1.39B | +19.3% |
| Operating Income | $1.02B | -1.4% |
| Pre-tax Income | $910.6M | +3.9% |
| Income Tax | -$39.5M | -147.2% |
| Net Income | $950.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $180.5M | +20.9% |
| Accounts Receivable | $257.7M | -15.7% |
| Inventory | $356.3M | -7.5% |
| Current Assets | $872.3M | -4.2% |
| Total Assets | $4.81B | +3.6% |
| Current Liabilities | $740.2M | +6.0% |
| Long-term Debt | $1.35B | -17.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $992.5M | +6.7% |
| Capital Expenditures | $69.3M | -40.0% |
| Investing Cash Flow | -$69.3M | +40.0% |
| Financing Cash Flow | -$886.0M | -3.1% |
| Free Cash Flow | $923.1M | +13.3% |
| +19.9% |
| EPS (Basic) | $16.00 | +23.9% |
| EPS (Diluted) | $15.88 | +24.2% |
| Total Liabilities |
| $2.98B |
| -6.7% |
| Stockholders' Equity | $1.84B | +26.3% |